Unibest
← Back to patent-cliff list

CAS 99-04-7

3-Methylbenzoic acidm-Toluic acid

Codes: MONT-039

Application context (from source-drug indications)

Allergic rhinitisMontelukastAsthmaMontelukastHypersensitivity reactionMontelukastSeasonal allergic rhinitisMontelukastPerennial allergic rhinitisMontelukastExercise-induced asthmaMontelukast

Source drugs (routes using this intermediate)

DrugTierExpiry
MontelukastTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

MontelukastOptimised routesteps: 7total yield: /
3-Methylbenzoic acidm-Toluic acid→3-Methylbenzoic acid methyl ester→methyl 3-(bromomethyl)benzoate→3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]benzoic acid methyl ester→7-Chloro-2-methylquinoline 7-Chloroquinaldine→3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]benzoic acid methyl ester→3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]benzoic acid→3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]benzoyl chloride→potassium 3-ethoxy-3-oxopropanoate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.